|
Protein
Controls Tumor's Blood Supply
Excerpt
By Merritt McKinney, Reuters Health
NEW YORK (Reuters Health)
- Scientists have uncovered evidence that a naturally occurring
protein suppresses the growth of cancerous tumors, most likely
through its control of a molecule involved in supplying blood
to tumors.
The research suggests that the protein, known as thrombospondin-1
(TSP1), holds promise as a tumor-suppressing treatment, the study's
lead author told Reuters Health.
``Our body has several regulatory mechanisms in place to block
cancer progression,'' Dr. M. Luisa Iruela-Arispe, of the Jonsson
Comprehensive Cancer Center at the University of California, Los
Angeles, explained.
Scientists have suspected that TSP1 inhibits angiogenesis, the
process by which tumors form vessels to supply themselves with
blood. Since tumors cannot survive without an adequate blood supply,
researchers have been testing compounds that block angiogenesis
to see whether they can stop or even reverse tumor growth.
In an article that will be published in the October 23rd issue
of the journal Proceedings of the National Academy of Sciences,
Iruela-Arispe and her colleagues report proof that TSP1 suppresses
tumors.
The researchers compared a strain of mice with breast cancer
that were genetically engineered to have excess levels of TSP1
with another strain that did not have any TSP1.
Mice that lacked TSP1 had more tumors and wider and more numerous
tumor-supplying vessels than expected. In contrast, mice that
had high levels of TSP1 had fewer tumors. They also had fewer,
narrower blood vessels.
Iruela-Arispe and her colleagues also found that mice with no
TSP1 had higher levels of a blood vessel growth factor as well
as increased levels of a molecule called MMP9.
Further testing suggested that TSP1's effects on MMP9 might account
for its tumor-suppressing abilities. In laboratory experiments,
the researchers found that TSP1 suppressed the activity of MMP9,
which encourages angiogenesis and helps tumors spread to other
organs, or metastasize.
Based on the findings, Iruela-Arispe concluded that TSP1 ''is
likely to be a good candidate for suppression of angiogenesis
in tumors.''
SOURCE: Proceedings of the National Academy of Sciences 2001;98:12485-
Reference
Source 89
For more information on how to prevent other diseases, use
PreventDisease.com's "Quick
Prevention Resources".
|